Kiconco, R.; Lumumba, S.A.; Bagenda, C.N.; Atwine, R.; Ndarubweine, J.; Rugera, S.P. Insulin Therapy among Diabetic Patients in Rural Communities of Sub-Saharan Africa: A Perspective Review. Therapeutic Advances in Endocrinology and Metabolism 2024, 15, doi:10.1177/20420188241232280.
Kiconco, R.; Lumumba, S.A.; Bagenda, C.N.; Atwine, R.; Ndarubweine, J.; Rugera, S.P. Insulin Therapy among Diabetic Patients in Rural Communities of Sub-Saharan Africa: A Perspective Review. Therapeutic Advances in Endocrinology and Metabolism 2024, 15, doi:10.1177/20420188241232280.
Kiconco, R.; Lumumba, S.A.; Bagenda, C.N.; Atwine, R.; Ndarubweine, J.; Rugera, S.P. Insulin Therapy among Diabetic Patients in Rural Communities of Sub-Saharan Africa: A Perspective Review. Therapeutic Advances in Endocrinology and Metabolism 2024, 15, doi:10.1177/20420188241232280.
Kiconco, R.; Lumumba, S.A.; Bagenda, C.N.; Atwine, R.; Ndarubweine, J.; Rugera, S.P. Insulin Therapy among Diabetic Patients in Rural Communities of Sub-Saharan Africa: A Perspective Review. Therapeutic Advances in Endocrinology and Metabolism 2024, 15, doi:10.1177/20420188241232280.
Abstract
In this perspective review, we describe a brief background on the status quo of diabetes mellitus related therapies and glycemic control among patients in rural communities of sub Saharan Africa. We specifically talk about insulin therapy and the challenges of access to insulin and oral hypoglycemic therapies among the diabetic patients living in sub-Saharan Africa. We crown up our discussion with suggestions on solutions and opportunities for future research to tackle this health challenge in these impoverished communities. Our ideas have been informed by the following inquiries: What is the current situation with diabetes in Sub-Saharan Africa? How well controlled are blood sugar levels among diabetes individuals in Sub-Saharan Africa? What is insulin therapy, and for which patient populations is it recommended? What proportions of diabetic patients are on insulin therapy and oral hypoglycemic drugs in Sub-Saharan Africa? Which is the most common therapy given to diabetic patients in the rural communities of sub Saharan Africa between insulin and oral hypoglycemic drugs? Who determines the choice of therapy between insulin and oral hypoglycemic drugs? How often is hypoglycemia and hyperglycemia encountered among people on insulin therapy? Is monitoring glucagon levels important for treating diabetic individuals receiving insulin? Is it normal practice to check the glucagon levels of diabetes patients in sub-Saharan African rural communities? What insulin therapy research has been done in the rural communities of sub Saharan Africa and what research gaps exist in this field? Addressing these research gaps is critical for improving insulin therapy in rural communities of sub-Saharan Africa and reducing the burden of diabetes in these populations.
Medicine and Pharmacology, Endocrinology and Metabolism
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
,
,
,
,
,
